|
COPYRIGHT 2003 International Medical News Group
GAITHERSBURG, Mo.-- A federal advisory panel has recommended that suppressive therapy with valacyclovir be approved for reducing the risk of genital herpes transmission from infected to uninfected sexual partners.
The Food and Drug Administration's Antiviral Drugs Advisory Committee voted 13-0 to support use of the drug for this indication in monogamous, heterosexual couples. The FDA usually follows the recommendations of its advisory panels, which are not binding. The panel based its decision on a landmark study that found suppressive treatment of infected...
Read the full article for free courtesy of your local library.
| 
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
